News Releases

Bioness® to Exhibit at American Occupational Therapy Assocation's 96th Annual Conference
Company showcases solutions at booth #5230 to help improve clinician efficiency and drive patient outcomes

VALENCIA, Calif., April 7, 2016 /PRNewswire/ -- Bioness Inc., the leading provider of cutting edge, clinically supported rehabilitation therapies, today announced the Company will exhibit at the American Occupational Therapy Association (AOTA) Annual Conference in Chicago. From April 7-10, Bioness will join 10,000 occupational therapy clinicians, educators and students who are passionate about incorporating new technologies and innovative ways to help patients meet their goals and live life to the fullest.

With 5.5 million people suffering long-term disabilities from stroke the importance of rehabilitation has never been greater to improve functional capabilities, quality of life and community reintegration. During AOTA, Bioness will showcase its clinical solutions supporting all stages of stroke recovery for patients to improve their long-term quality of life.

Since 2004, Bioness has been an industry leader supporting efforts of skilled acute and outpatient practices. Attendees can view the following Bioness offerings at AOTA booth #5230:

Bioness Integrated Therapy System (BITS®) Version 2: The second generation of BITS software is designed to address the changing dynamics of the rehabilitation market by improving clinician efficiency with automated progress reports, personalized therapy programs and standardized outcome measures. The new BITS Reports Module calculates key performance metrics and makes generating quality, value-added reports easier than ever before.

StimRouter Neuromodulation System: A minimally invasive, implantable, surgical device designed to address chronic peripheral nerve pain. With an estimated 100 million people suffering from chronic pain, contributing more than $280 billion in annual costs to the U.S. healthcare system, there's never been a greater need for innovative pain management options.1 Specific to rehabilitation, shoulder pain is a common disability resulting from a central nervous system trauma (e.g. stroke). This pain traditionally originates at the axillary nerve, a peripheral nerve in the upper arm, and has been reported to occur in up to 85% of stroke survivors.2 StimRouter is designed to target pain at the point of origin, minimize long-term healthcare costs and may provide pain relief when other treatments such as medications and injections have limited effect.3

H200® Wireless Hand Rehabilitation System: With more than 20 peer-reviewed and published clinical studies, the H200 System has been clinically shown to improve hand and upper extremity function during all stages of stroke rehabilitation. The System delivers non-invasive functional electrical stimulation (FES) to improve hand function, reduce muscle spasms and prevent disuse atrophy. H200 Wireless is widely used in the Veterans Administration to promote functional hand use in spinal cord injury patients that lack the ability to perform activities of daily including grasping and releasing hand movements. 

To experience Bioness first hand, visit AOTA booth #5230. Attendees can participate in experiential demonstrations and be among the first to experience Bioness pain management and software therapy programs.

About Bioness Inc.
Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include external and implantable functional electrical stimulation (FES) systems, robotic systems and software-based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries.

Bioness markets its technologies directly to individuals with neurological conditions and to healthcare professionals including interventional physicians, physiatrists (physical medicine and rehabilitation physicians), neurologists and all therapy disciplines.  Bioness' technologies are offered at over 80% of the leading US rehabilitation hospitals, including the largest inpatient hospital network, HealthSouth, and the US Department of Veterans Affairs. 

Individual results vary. Consult with a qualified physician to determine if this product is right for you. Contraindications, adverse reactions and precautions are available online at

Bioness®, BITS®, H200®, StimRouter™ are trademarks of Bioness Inc. | | Rx Only

Additional information about BITS can be found at
Additional information about StimRouter can be found at

1 Institute of Medicine (US). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. 2011. The National Academies.
2 Van Ouwenaller, C. et al. 1986. Archives of Physical Medicine and Rehabilitation. 67, 23–26.
3 Deer T, et al. 2016. Neuromodulation. 19:91-100.

Media Contact:
Nigel Smith
Next Step Communications


SOURCE Bioness Inc.